Maxillofacial Plastic and Reconstructive Surgery

  • Volume 41
  • /
  • Pages.47.1-47.10
  • /
  • 2019
  • /
  • 2288-8101(pISSN)
  • /
  • 2288-8586(eISSN)
Korean Association of Maxillofacial Plastic and Reconstructive Surgeons (대한악안면성형재건외과학회)
권호 표지
DOI QR코드

DOI QR Code

Effect of bFGF and fibroblasts combined with hyaluronic acid-based hydrogels on soft tissue augmentation: an experimental study in rats

  • Lee, Su Yeon (Department of Oral and Maxillofacial Surgery, Dental Research Institute, School of Dentistry, Seoul National University) ;
  • Park, Yongdoo (Department of Biomedical Engineering, Korea University Medical College) ;
  • Hwang, Soon Jung (HSJ Dental Clinic for Oral and Maxillofacial Surgery)
  • Received : 2019.09.02
  • Accepted : 2019.10.03
  • Published : 2019.12.31
Download PDF
⟨ Previous Next ⟩

Abstract

Background: Hyaluronic acid (HA) has been applied as a primary biomaterial for temporary soft tissue augmentation and as a carrier for cells and the delivery of growth factors to promote tissue regeneration. Although HA derivatives are the most versatile soft tissue fillers on the market, they are resorbed early, within 3 to 12 months. To overcome their short duration, they can be combined with cells or growth factors. The purpose of this study was to investigate the stimulating effects of human fibroblasts and basic fibroblast growth factors (bFGF) on collagen synthesis during soft tissue augmentation by HA hydrogels and to compare these with the effects of a commercial HA derivative (Restylane®). Methods: The hydrogel group included four conditions. The first condition consisted of hydrogel (H) alone as a negative control, and the other three conditions were bFGF-containing hydrogel (HB), human fibroblast-containing hydrogel (HF), and human fibroblast/bFGF-containing hydrogel (HBF). In the Restylane® group (HGF), the hydrogel was replaced with Restylane® (R, RB, RF, RBF). The gels were implanted subdermally into the back of each nude mouse at four separate sites. Twelve nude mice were used for the hydrogel (n = 6) and Restylane® groups (n = 6). The specimens were harvested 8 weeks after implantation and assessed histomorphometrically, and collagen synthesis was evaluated by RT-PCR. Results: The hydrogel group showed good biocompatibility with the surrounding tissues and stimulated the formation of a fibrous matrix. HBF and HF showed significantly higher soft tissue synthesis compared to H (p < 0.05), and human collagen type I was well expressed in HB, HF, and HBF; HBF showed the strongest expression. The Restylane® filler was surrounded by a fibrous capsule without any soft tissue infiltration from the neighboring tissue, and collagen synthesis within the Restylane® filler could not be observed, even though no inflammatory reactions were observed. Conclusion: This study revealed that HA-based hydrogel alone or hydrogel combined with fibroblasts and/or bFGF can be effectively used for soft tissue augmentation.

Keywords

References

  1. Kasper DA, Cohen JL, Saxena A, Morganroth GS (2008) Fillers for postsurgical depressed scars after skin cancer reconstruction. J Drugs Dermatol 7:486-487
  2. Fagien S, Klein AW (2007) A brief overview and history of temporary fillers: evolution, advantages, and limitations. Plast Reconstr Surg 120:8S-16S https://doi.org/10.1097/01.prs.0000248788.97350.18
  3. Klein AW (2006) Soft tissue augmentation 2006: filler fantasy. Dermatol Ther 19:129-133 https://doi.org/10.1111/j.1529-8019.2006.00066.x
  4. Fernandez EM, Mackley CL (2006) Soft tissue augmentation: a review. J Drugs Dermatol 5:630-641
  5. Eppley BL, Dadvand B (2006) Injectable soft-tissue fillers: clinical overview. Plast Reconstr Surg 118:98e-106e https://doi.org/10.1097/01.prs.0000232436.91409.30
  6. Fernandez-Cossio S, Castano-Oreja MT (2006) Biocompatibility of two novel dermal fillers: histological evaluation of implants of a hyaluronic acid filler and a polyacrylamide filler. Plast Reconstr Surg 117:1789-1796 https://doi.org/10.1097/01.prs.0000214656.07273.b0
  7. Jeyanthi R, Rao KP (1990) In vivo biocompatibility of collagen-poly (hydroxyethyl methacrylate) hydrogels. Biomaterials 11:238-243 https://doi.org/10.1016/0142-9612(90)90004-A
  8. Brandt FS, Cazzaniga A (2007) Hyaluronic acid fillers: Restylane and Perlane. Facial Plast Surg Clin North Am 15(63-76):vii https://doi.org/10.1016/j.fsc.2006.11.002
  9. Born T (2006) Hyaluronic acids. Clin Plast Surg 33:525-538 https://doi.org/10.1016/j.cps.2006.09.005
  10. Hoemann CD, Sun J, Legare A, McKee MD, Buschmann MD (2005) Tissue engineering of cartilage using an injectable and adhesive chitosan-based cell-delivery vehicle. Osteoarthr Cartil 13:318-329 https://doi.org/10.1016/j.joca.2004.12.001
  11. Nuttelman CR, Tripodi MC, Anseth KS (2006) Dexamethasone-functionalized gels induce osteogenic differentiation of encapsulated hMSCs. J Biomed Mater Res A 76:183-195 https://doi.org/10.1002/jbm.a.30537
  12. Hong L, Tabata Y, Yamamoto M, Miyamoto S, Yamada K, Hashimoto N et al (1998) Comparison of bone regeneration in a rabbit skull defect by recombinant human BMP-2 incorporated in biodegradable hydrogel and in solution. J Biomater Sci Polym Ed 9:1001-1014 https://doi.org/10.1163/156856298X00307
  13. Fini M, Motta A, Torricelli P, Giavaresi G, Nicoli Aldini N, Tschon M et al (2005) The healing of confined critical size cancellous defects in the presence of silk fibroin hydrogel. Biomaterials 26:3527-3536 https://doi.org/10.1016/j.biomaterials.2004.09.040
  14. Hokugo A, Ozeki M, Kawakami O, Sugimoto K, Mushimoto K, Morita S et al (2005) Augmented bone regeneration activity of platelet-rich plasma by biodegradable gelatin hydrogel. Tissue Eng 11:1224-1233 https://doi.org/10.1089/ten.2005.11.1224
  15. Kim J, Kim IS, Cho TH, Lee KB, Hwang SJ, Tae G et al (2007) Bone regeneration using hyaluronic acid-based hydrogel with bone morphogenic protein-2 and human mesenchymal stem cells. Biomaterials 28:1830-1837 https://doi.org/10.1016/j.biomaterials.2006.11.050
  16. Alsberg E, Anderson KW, Albeiruti A, Franceschi RT, Mooney DJ (2001) Cellinteractive alginate hydrogels for bone tissue engineering. J Dent Res 80:2025-2029 https://doi.org/10.1177/00220345010800111501
  17. Silverman RP, Passaretti D, Huang W, Randolph MA, Yaremchuk MJ (1999) Injectable tissue-engineered cartilage using a fibrin glue polymer. Plast Reconstr Surg 103:1809-1818 https://doi.org/10.1097/00006534-199906000-00001
  18. Oest ME, Dupont KM, Kong HJ, Mooney DJ, Guldberg RE (2007) Quantitative assessment of scaffold and growth factor-mediated repair of critically sized bone defects. J Orthop Res 25:941-950 https://doi.org/10.1002/jor.20372
  19. Yang F, Williams CG, Wang DA, Lee H, Manson PN, Elisseeff J (2005) The effect of incorporating RGD adhesive peptide in polyethylene glycol diacrylate hydrogel on osteogenesis of bone marrow stromal cells. Biomaterials 26:5991-5998 https://doi.org/10.1016/j.biomaterials.2005.03.018
  20. Laurent TC, Laurent UB, Fraser JR (1995) Functions of hyaluronan. Ann Rheum Dis 54:429-432 https://doi.org/10.1136/ard.54.5.429
  21. Prestwich GD, Marecak DM, Marecek JF, Vercruysse KP, Ziebell MR (1998) Controlled chemical modification of hyaluronic acid: synthesis, applications, and biodegradation of hydrazide derivatives. J Control Release 53:93-103 https://doi.org/10.1016/S0168-3659(97)00242-3
  22. You HJ, Namgoong S, Rhee SM, Han SK (2016) Tracking and increasing viability of topically injected fibroblasts suspended in hyaluronic acid filler. J Craniofac Surg 27:521-525 https://doi.org/10.1097/SCS.0000000000002518
  23. Solakoglu S, Tiryaki T, Ciloglu SE (2008) The effect of cultured autologous fibroblasts on longevity of cross-linked hyaluronic acid used as a filler. Aesthet Surg J 28:412-416 https://doi.org/10.1016/j.asj.2008.04.008
  24. Yoon ES, Han SK, Kim WK (2003) Advantages of the presence of living dermal fibroblasts within restylane for soft tissue augmentation. Ann Plast Surg 51:587-592 https://doi.org/10.1097/01.sap.0000096424.23397.2a
  25. Moon KC, Kim KB, Han SK, Jeong SH, Dhong ES (2019) Assessment of longterm outcomes of soft-tissue augmentation by injecting fibroblasts suspended in hyaluronic acid filler. JAMA Facial Plast Surg 21:312-318
  26. Draelos ZD (2016) The effect of a combination of recombinant EGF cosmetic serum and a crosslinked hyaluronic acid serum as compared to a fibroblast-conditioned media serum on the appearance of aging skin. J Drugs Dermatol 15:738-741
  27. Hoben G, Schmidt VJ, Bannasch H, Horch RE (2011) Tissue augmentation with fibrin sealant and cultured fibroblasts: a preliminary study. Aesthetic Plast Surg 35:1009-1015 https://doi.org/10.1007/s00266-011-9724-x
  28. Schmidt A, Ladage D, Schinkothe T, Klausmann U, Ulrichs C, Klinz FJ et al (2006) Basic fibroblast growth factor controls migration in human mesenchymal stem cells. Stem Cells 24:1750-1758 https://doi.org/10.1634/stemcells.2005-0191
  29. Ozaki Y, Nishimura M, Sekiya K, Suehiro F, Kanawa M, Nikawa H et al (2007) Comprehensive analysis of chemotactic factors for bone marrow mesenchymal stem cells. Stem Cells Dev 16:119-129 https://doi.org/10.1089/scd.2006.0032
  30. Abramoff MD, Magelhaes PJ, Ram SJ (2004) Image processing with image J. Biophotonics Int 11:36-42
  31. Moscona R, Ullman Y, Har-Shai Y, Hirshowitz B (1989) Free-fat injections for the correction of hemifacial atrophy. Plast Reconstr Surg 84:501-507 discussion 8-9 https://doi.org/10.1097/00006534-198909000-00020
  32. Horl HW, Feller AM, Biemer E (1991) Technique for liposuction fat reimplantation and long-term volume evaluation by magnetic resonance imaging. Ann Plast Surg 26:248-258 https://doi.org/10.1097/00000637-199103000-00007
  33. Toledo LS, Mauad R (2006) Fat injection: a 20-year revision. Clin Plast Surg 33(47-53):vi https://doi.org/10.1016/j.cps.2005.08.002
  34. Matarasso SL (2006) The use of injectable collagens for aesthetic rejuvenation. Semin Cutan Med Surg 25:151-157 https://doi.org/10.1016/j.sder.2006.08.008
  35. Zimmermann US, Clerici TJ (2004) The histological aspects of fillers complications. Semin Cutan Med Surg 23:241-250 https://doi.org/10.1016/j.sder.2004.09.004
  36. Lemperle G, Morhenn V, Charrier U (2003) Human histology and persistence of various injectable filler substances for soft tissue augmentation. Aesthetic Plast Surg 27:354-366 discussion 67 https://doi.org/10.1007/s00266-003-3022-1
  37. Wei YT, Tian WM, Yu X, Cui FZ, Hou SP, Xu QY et al (2007) Hyaluronic acid hydrogels with IKVAV peptides for tissue repair and axonal regeneration in an injured rat brain. Biomed Mater 2:S142-S146 https://doi.org/10.1088/1748-6041/2/3/S11
  38. Zawko SA, Truong Q, Schmidt CE (2008) Drug-binding hydrogels of hyaluronic acid functionalized with beta-cyclodextrin. J Biomed Mater Res A 87:1044-1052 https://doi.org/10.1002/jbm.a.31845
  39. Cai S, Liu Y, Zheng Shu X, Prestwich GD (2005) Injectable glycosaminoglycan hydrogels for controlled release of human basic fibroblast growth factor. Biomaterials 26:6054-6067 https://doi.org/10.1016/j.biomaterials.2005.03.012
  40. Fernandez-Cossio S, Leon-Mateos A, Sampedro FG, Oreja MT (2007) Biocompatibility of agarose gel as a dermal filler: histologic evaluation of subcutaneous implants. Plast Reconstr Surg 120:1161-1169 https://doi.org/10.1097/01.prs.0000279475.99934.71
  41. von Buelow S, von Heimburg D, Pallua N (2005) Efficacy and safety of polyacrylamide hydrogel for facial soft-tissue augmentation. Plast Reconstr Surg 116:1137-1146 discussion 47-8 https://doi.org/10.1097/01.prs.0000179349.14392.a4
  42. Bello G, Jackson IT, Keskin M, Kelly C, Dajani K, Studinger R et al (2007) The use of polyacrylamide gel in soft-tissue augmentation: an experimental assessment. Plast Reconstr Surg 119:1326-1336 https://doi.org/10.1097/01.prs.0000254824.13065.3b
  43. Lahiri A, Waters R (2007) Experience with Bio-Alcamid, a new soft tissue endoprosthesis. J Plast Reconstr Aesthet Surg 60:663-667 https://doi.org/10.1016/j.bjps.2006.07.010
  44. Ramires PA, Miccoli MA, Panzarini E, Dini L, Protopapa C (2005) In vitro and in vivo biocompatibility evaluation of a polyalkylimide hydrogel for soft tissue augmentation. J Biomed Mater Res B Appl Biomater 72:230-238
  45. Marler JJ, Guha A, Rowley J, Koka R, Mooney D, Upton J et al (2000) Softtissue augmentation with injectable alginate and syngeneic fibroblasts. Plast Reconstr Surg 105:2049-2058 https://doi.org/10.1097/00006534-200005000-00020
  46. Loebsack A, Greene K, Wyatt S, Culberson C, Austin C, Beiler R et al (2001) In vivo characterization of a porous hydrogel material for use as a tissue bulking agent. J Biomed Mater Res 57:575-581 https://doi.org/10.1002/1097-4636(20011215)57:4<575::AID-JBM1204>3.0.CO;2-9
  47. Halberstadt C, Austin C, Rowley J, Culberson C, Loebsack A, Wyatt S et al (2002) A hydrogel material for plastic and reconstructive applications injected into the subcutaneous space of a sheep. Tissue Eng 8:309-319 https://doi.org/10.1089/107632702753725067
  48. Gurtner GC, Werner S, Barrandon Y, Longaker MT (2008) Wound repair and regeneration. Nature 453:314-321 https://doi.org/10.1038/nature07039
  49. Montesano R, Vassalli JD, Baird A, Guillemin R, Orci L (1986) Basic fibroblast growth factor induces angiogenesis in vitro. Proc Natl Acad Sci U S A 83:7297-7301 https://doi.org/10.1073/pnas.83.19.7297
  50. McGee GS, Davidson JM, Buckley A, Sommer A, Woodward SC, Aquino AM et al (1988) Recombinant basic fibroblast growth factor accelerates wound healing. J Surg Res 45:145-153 https://doi.org/10.1016/0022-4804(88)90034-0
  51. Schweigerer L (1988) Basic fibroblast growth factor as a wound healing hormone. Trends Pharmacol Sci 9:427-428 https://doi.org/10.1016/0165-6147(88)90125-3
  52. Nillesen ST, Geutjes PJ, Wismans R, Schalkwijk J, Daamen WF, van Kuppevelt TH (2006) Increased angiogenesis in acellular scaffolds by combined release of FGF2 and VEGF. J Control Release 116:e88-e90 https://doi.org/10.1016/j.jconrel.2006.09.065
  53. Wong T, McGrath JA, Navsaria H (2007) The role of fibroblasts in tissue engineering and regeneration. Br J Dermatol 156:1149-1155 https://doi.org/10.1111/j.1365-2133.2007.07914.x
  54. Fujita M, Ishihara M, Simizu M, Obara K, Ishizuka T, Saito Y et al (2004) Vascularization in vivo caused by the controlled release of fibroblast growth factor-2 from an injectable chitosan/non-anticoagulant heparin hydrogel. Biomaterials 25:699-706 https://doi.org/10.1016/S0142-9612(03)00557-X
  55. Keller G, Sebastian J, Lacombe U, Toft K, Lask G, Revazova E (2000) Safety of injectable autologous human fibroblasts. Bull Exp Biol Med 130:786-789 https://doi.org/10.1007/BF02766096
  56. Weiss RA, Weiss MA, Beasley KL, Munavalli G (2007) Autologous cultured fibroblast injection for facial contour deformities: a prospective, placebocontrolled, phase III clinical trial. Dermatol Surg 33:263-268 https://doi.org/10.1097/00042728-200703000-00001
  57. Han SK, Shin SH, Kang HJ, Kim WK (2006) Augmentation rhinoplasty using injectable tissue-engineered soft tissue: a pilot study. Ann Plast Surg 56:251-255 https://doi.org/10.1097/01.sap.0000198549.64341.17
  58. Park DJ, Choi JH, Kim YJ, Kim JH, Kim KT (2006) Nasal augmentation using injectable alginate and mesenchymal stem cells in the rabbit. Am J Rhinol 20:520-523 https://doi.org/10.2500/ajr.2006.20.2926

Cited by

  1. A New Method Involving Percutaneous Application in the Treatment of Deep Venous Insufficiency: An Experimental Study With Internal Compression Therapy in a Porcine Model vol.55, pp.2, 2019, https://doi.org/10.1177/1538574420966113
  2. Recent Progress on Polysaccharide-Based Hydrogels for Controlled Delivery of Therapeutic Biomolecules vol.7, pp.9, 2019, https://doi.org/10.1021/acsbiomaterials.0c01784